Vimarsana
Biggest News Aggregation in the World

Page 19 - Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Inc Today - Breaking & Trending Today

IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a "Buy" Recommendation and $3.00 Price Target -February 23, 2024 at 12:02 pm EST - Vimarsana News

IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a "Buy" Recommendation and $3.00 Price Target -February 23, 2024 at 12:02 pm EST

IGC Pharma, Inc. announces that Ascendiant Capital Markets LLC has issued an analyst coverage research report on the Company’s common stock. All reports on IGC Pharma prepared by analysts...

Emerald Health Therapeutics (CVE:EMH) Shares Down 3.8% - Vimarsana News

Emerald Health Therapeutics (CVE:EMH) Shares Down 3.8%

Shares of Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) dropped 3.8% during trading on Tuesday . The company traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares changed hands during trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at […]

IGC Pharma Reports Third Quarter Fiscal 2024 Results - Vimarsana News

IGC Pharma Reports Third Quarter Fiscal 2024 Results

IGC Pharma, Inc. today announced its financial results for the third fiscal quarter of 2024 ended December 31, 2023 . Q3 FY2024 Highlights On October 18, 2023, the European Patent Office ...

FSD Pharma Announces US ATM Offering - Vimarsana News

FSD Pharma Announces US ATM Offering

TORONTO, ON / ACCESSWIRE / February 16, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and

MEI Pharma (NASDAQ:MEIP) Price Target Cut to $7.00 by Analysts at Stifel Nicolaus - Vimarsana News

MEI Pharma (NASDAQ:MEIP) Price Target Cut to $7.00 by Analysts at Stifel Nicolaus

MEI Pharma (NASDAQ:MEIP – Free Report) had its price objective trimmed by Stifel Nicolaus from $8.00 to $7.00 in a research note issued to investors on Wednesday morning, Benzinga reports. The firm currently has a hold rating on the stock. MEIP has been the topic of a number of other reports. StockNews.com downgraded shares of […]

Source: wkrb13.com